Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Korean Med Sci. 2012 Nov;27(11):1327-32. doi: 10.3346/jkms.2012.27.11.1327. Epub 2012 Oct 30.

Quality of life and disease severity are correlated in patients with atopic dermatitis.

Author information

  • 1Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.

Abstract

Quantification of quality of life (QOL) related to disease severity is important in patients with atopic dermatitis (AD), because the assessment provides additional information to the traditional objective clinical scoring systems. To document the impact of AD on QOL for both children and adults as well as to quantify the relationship with disease severity, QOL assessments were performed over a 6-month period on 415 patients with AD. A questionnaire derived from the Infants' Dermatitis Quality of Life Index (IDQOL), the Children's Dermatology Life Quality Index (CDLQI) and the Dermatology Life Quality Index (DLQI) was used to determine the QOL for 71 infants, 197 children and 147 adults, respectively. To measure AD severity, both the Rajka & Langeland scoring system and the Scoring of Atopic Dermatitis (SCORAD) index were used. The mean scores were as follows: 7.7 ± 5.5 for IDQOL, 6.6 ± 6.3 for CDLQI, and 10.7 ± 7.9 for DLQI. In conclusion, these QOL scores are correlated with AD severity scores as estimated by the Rajka & Langeland severity score and the SCORAD. The outcome of the QOL instruments in this study demonstrates that atopic dermatitis of both children and adults affects their QOL.

KEYWORDS:

Atopic Dermatitis; Disease Severity; Quality of Life

PMID:
23166413
[PubMed - indexed for MEDLINE]
PMCID:
PMC3492666
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Korean Academy of Medical Sciences Icon for PubMed Central
    Loading ...
    Write to the Help Desk